MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 145 filers reported holding MACROGENICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,792,500 | +24.0% | 250,000 | +52.3% | 0.41% | +114.2% |
| Q1 2022 | $1,446,000 | -42.3% | 164,119 | +5.2% | 0.19% | -49.1% |
| Q4 2021 | $2,506,000 | -81.1% | 156,047 | -75.4% | 0.37% | -60.1% |
| Q3 2021 | $13,287,000 | -34.9% | 634,478 | -16.5% | 0.94% | -43.2% |
| Q2 2021 | $20,401,000 | -8.6% | 759,602 | +8.4% | 1.65% | +119.9% |
| Q1 2021 | $22,311,000 | +965.0% | 700,469 | +94.6% | 0.75% | +374.7% |
| Q1 2020 | $2,095,000 | +20.3% | 360,030 | +125.0% | 0.16% | -44.0% |
| Q4 2019 | $1,741,000 | – | 160,030 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,215,675 | $6,503,861 | 2.01% |
| Bellevue Group AG | 9,609,913 | $51,413,035 | 0.73% |
| Frazier Life Sciences Management, L.P. | 1,803,204 | $9,647,141 | 0.58% |
| ARMISTICE CAPITAL, LLC | 5,600,000 | $29,960,000 | 0.43% |
| Delphia (USA) Inc. | 37,988 | $203,236 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 352,497 | $1,885,859 | 0.31% |
| Corton Capital Inc. | 73,678 | $394,177 | 0.18% |
| Rock Springs Capital Management LP | 1,123,096 | $6,008,564 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 129,158 | $691 | 0.07% |
| PINNACLE ASSOCIATES LTD | 709,903 | $3,797,981 | 0.07% |